We value strategic partnerships for scientific advancement, with the goal of pushing scientific boundaries and impacting patients’ lives. Our collaboration will continue to progress.
NUVISAN The Science CRO has received a $9.6 million grant from the Bill & Melinda Gates Foundation for breakthrough discovery and early development of new non-hormonal contraceptives.
NUVISAN ICB was awarded the 2023 EcoVadis Gold Medal for Sustainability, which highlights our commitment to reducing our carbon footprint and making a positive impact on the community. Thank you to EcoVadis for recognizing our work!
Explore NUVISAN's scientific publications, videos, webinars, and more to gain insights into our solutions and projects, and see how our teams can support your scientific journey.
We offer unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain to our biotech startup, pharma, non-profit, and venture capital clients – from target identification to the patient.
Thanks to more than 40 years of experience and about 1,000 employees (incl. >70 % industry experienced scientists and lab professionals), we know how to discover, develop, and bring the next generation medicines to market. At the same time, our scientists understand that every project is different. With a flexible and innovative approach and transparent communication, our teams are passionate about closely collaborating with you to adapt to your individual needs.